SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001651308-20-000140
Filing Date
2020-08-26
Accepted
2020-08-26 16:47:04
Documents
2
Period of Report
2020-08-24

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_159847480362064.html 3  
1 FORM 3 wf-form3_159847480362064.xml 3 1765
2 POWEROFATTORNEYCS powerofattorneycsanders.htm EX-24 8405
  Complete submission text file 0001651308-20-000140.txt   11644
Mailing Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Issuer) CIK: 0001651308 (see all company filings)

IRS No.: 981209416 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MOLECULAR TEMPLATES, INC. 9301 AMBERGLEN BLVD, SUITE 100 AUSTIN VI 78729
Business Address
Sanders Corazon (Corsee) D. (Reporting) CIK: 0001796536 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37686 | Film No.: 201137807